Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001783664 | SCV002019023 | likely pathogenic | not provided | 2021-03-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868867 | SCV002136991 | pathogenic | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2022-01-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1324987). This variant has not been reported in the literature in individuals affected with RAPSN-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu227*) in the RAPSN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAPSN are known to be pathogenic (PMID: 17686188). |